Tapewire

NYSE · USD

CSW

CSW INDUSTRIALS, INC.

Export transactions ↓
Tapewire entity
3917
SEC CIK
0001624794
Parsed reports
426

Last 12 months

Inside the activity.

1 purchase rows · 23 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202505
Jan 202602
Feb 202602
Mar 202611
Apr 202603
May 202602
Jun 202601
Jul 202601
Aug 202603
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 02, 2025 Filed Apr 4, 2025 21:01 UTC
UNDERWOOD JEFFSVP, GM Contractor Solutions
Exercise / conversionCommon Stock 1,720 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000027 · wk-form4_1743800506.xml · nonDerivative · entry 1

UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 17 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:06 UTC
Alverson LukeSVP, GC & Secretary
Exercise / conversionPerformance Rights · Derivative 1,500 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000029 · wk-form4_1743800768.xml · derivative · entry 4

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 26 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 26 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 26 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:06 UTC
Alverson LukeSVP, GC & Secretary
Tax withholdingCommon Stock 1,214 $295.91 $359,234.74
Disclosure

SEC source: 0001624794-25-000029 · wk-form4_1743800768.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,272

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:06 UTC
Alverson LukeSVP, GC & Secretary
Exercise / conversionCommon Stock 3,052 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000029 · wk-form4_1743800768.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,486

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 26 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:07 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionPerformance Rights · Derivative 7,851 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000031 · wk-form4_1743800863.xml · derivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,851 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 108 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 108 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 108 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:07 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionPerformance Rights · Derivative 9,187 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000031 · wk-form4_1743800863.xml · derivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,372

Underlying: Common Stock · 9,187 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of March 31, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,187 performance rights for the performance cycle ended March, 31, 2025, along with 169 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of March 31, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,187 performance rights for the performance cycle ended March, 31, 2025, along with 169 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of March 31, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,187 performance rights for the performance cycle ended March, 31, 2025, along with 169 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:07 UTC
Armes Joseph BDirector · Chairman, President & CEO
Tax withholdingCommon Stock 13,416 $295.91 $3,969,928.56
Disclosure

SEC source: 0001624794-25-000031 · wk-form4_1743800863.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,522

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:07 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 15,378 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000031 · wk-form4_1743800863.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 108 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:07 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 18,712 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000031 · wk-form4_1743800863.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,560

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of March 31, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,187 performance rights for the performance cycle ended March, 31, 2025, along with 169 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:07 UTC Exercise / conversionPerformance Rights · Derivative 2,948 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000030 · wk-form4_1743800814.xml · derivative · entry 4

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,948 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 45 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 45 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 45 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:07 UTC Tax withholdingCommon Stock 2,365 $295.91 $699,827.15
Disclosure

SEC source: 0001624794-25-000030 · wk-form4_1743800814.xml · nonDerivative · entry 2

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,758

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:07 UTC Exercise / conversionCommon Stock 5,986 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000030 · wk-form4_1743800814.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,123

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 45 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:05 UTC
Sullivan DonEVP, Chief Strategy Officer
Exercise / conversionPerformance Rights · Derivative 3,369 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000028 · wk-form4_1743800718.xml · derivative · entry 4

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,369 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 49 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 49 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 49 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:05 UTC
Sullivan DonEVP, Chief Strategy Officer
Tax withholdingCommon Stock 2,700 $295.91 $798,957.00
Disclosure

SEC source: 0001624794-25-000028 · wk-form4_1743800718.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,989

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:05 UTC
Sullivan DonEVP, Chief Strategy Officer
Exercise / conversionCommon Stock 6,836 $0.00 $0.00
Disclosure

SEC source: 0001624794-25-000028 · wk-form4_1743800718.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 49 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 01, 2025 Filed Apr 1, 2025 17:04 UTC SaleCommon Stock 200 $289.10 $57,820.00
Disclosure

SEC source: 0001624794-25-000026 · wk-form4_1743541446.xml · nonDerivative · entry 1

Swartz Robert M · CIK 0001413221 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,119

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 10, 2024.

Read SEC document
April 01, 2025 Filed Apr 1, 2025 21:03 UTC SaleCommon Stock 145 $289.10 $41,919.50
Disclosure

SEC source: 0001624794-25-000025 · wk-form4_1743541387.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,137

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 4, 2024.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:16 UTC
Alverson LukeSVP, GC & Secretary
SaleCommon Stock 20 $294.82 $5,896.40
Disclosure

SEC source: 0001624794-25-000023 · wk-form4_1742336206.xml · nonDerivative · entry 5

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,434

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 11, 2024.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:16 UTC
Alverson LukeSVP, GC & Secretary
SaleCommon Stock 103 $294.01 $30,283.03
Disclosure

SEC source: 0001624794-25-000023 · wk-form4_1742336206.xml · nonDerivative · entry 4

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,454

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 11, 2024.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.65 to $294.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:16 UTC
Alverson LukeSVP, GC & Secretary
SaleCommon Stock 165 $293.11 $48,363.15
Disclosure

SEC source: 0001624794-25-000023 · wk-form4_1742336206.xml · nonDerivative · entry 3

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,557

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 11, 2024.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.56 to $293.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:16 UTC
Alverson LukeSVP, GC & Secretary
SaleCommon Stock 428 $292.01 $124,980.28
Disclosure

SEC source: 0001624794-25-000023 · wk-form4_1742336206.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,722

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 11, 2024.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $291.55 to $292.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:16 UTC
Alverson LukeSVP, GC & Secretary
SaleCommon Stock 384 $291.18 $111,813.12
Disclosure

SEC source: 0001624794-25-000023 · wk-form4_1742336206.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,150

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 11, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $290.54 to $291.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:17 UTC
Sullivan DonEVP, Chief Strategy Officer
SaleCommon Stock 40 $294.82 $11,792.80
Disclosure

SEC source: 0001624794-25-000024 · wk-form4_1742336217.xml · nonDerivative · entry 5

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,853

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 13, 2024.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:17 UTC
Sullivan DonEVP, Chief Strategy Officer
SaleCommon Stock 209 $294.01 $61,448.09
Disclosure

SEC source: 0001624794-25-000024 · wk-form4_1742336217.xml · nonDerivative · entry 4

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,893

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 13, 2024.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.65 to $294.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:17 UTC
Sullivan DonEVP, Chief Strategy Officer
SaleCommon Stock 332 $293.11 $97,312.52
Disclosure

SEC source: 0001624794-25-000024 · wk-form4_1742336217.xml · nonDerivative · entry 3

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,102

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 13, 2024.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.56 to $293.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:17 UTC
Sullivan DonEVP, Chief Strategy Officer
SaleCommon Stock 864 $292.01 $252,296.64
Disclosure

SEC source: 0001624794-25-000024 · wk-form4_1742336217.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,434

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 13, 2024.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $291.55 to $292.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:17 UTC
Sullivan DonEVP, Chief Strategy Officer
SaleCommon Stock 777 $291.18 $226,246.86
Disclosure

SEC source: 0001624794-25-000024 · wk-form4_1742336217.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,298

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 13, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $290.54 to $291.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 22:16 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 315 $291.12 $91,702.80
Disclosure

SEC source: 0001624794-25-000022 · wk-form4_1742336195.xml · nonDerivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,848

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $290.98 to $291.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 22:16 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 227 $290.37 $65,913.99
Disclosure

SEC source: 0001624794-25-000022 · wk-form4_1742336195.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,163

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $289.98 to $290.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 22:16 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 300 $289.59 $86,877.00
Disclosure

SEC source: 0001624794-25-000022 · wk-form4_1742336195.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,390

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $288.97 to $289.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 22:16 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 82 $288.52 $23,658.64
Disclosure

SEC source: 0001624794-25-000022 · wk-form4_1742336195.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,690

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $287.93 to $288.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 22:16 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 67 $287.21 $19,243.07
Disclosure

SEC source: 0001624794-25-000022 · wk-form4_1742336195.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,772

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $286.87 to $287.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 22:16 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 9 $286.24 $2,576.16
Disclosure

SEC source: 0001624794-25-000022 · wk-form4_1742336195.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,839

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.81 to $286.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 03, 2025 Filed Mar 3, 2025 17:58 UTC SaleCommon Stock 100 $308.25 $30,825.00
Disclosure

SEC source: 0001624794-25-000021 · wk-form4_1741042700.xml · nonDerivative · entry 3

Swartz Robert M · CIK 0001413221 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,319

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 10, 2024.

Read SEC document
March 03, 2025 Filed Mar 3, 2025 17:58 UTC SaleCommon Stock 4 $306.71 $1,226.84
Disclosure

SEC source: 0001624794-25-000021 · wk-form4_1741042700.xml · nonDerivative · entry 2

Swartz Robert M · CIK 0001413221 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,419

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 10, 2024.

Read SEC document
March 03, 2025 Filed Mar 3, 2025 17:58 UTC SaleCommon Stock 96 $306.15 $29,390.40
Disclosure

SEC source: 0001624794-25-000021 · wk-form4_1741042700.xml · nonDerivative · entry 1

Swartz Robert M · CIK 0001413221 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,423

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 10, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.67 to $306.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 03, 2025 Filed Mar 3, 2025 22:57 UTC SaleCommon Stock 100 $308.25 $30,825.00
Disclosure

SEC source: 0001624794-25-000020 · wk-form4_1741042654.xml · nonDerivative · entry 2

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,282

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 4, 2024.

Read SEC document
March 03, 2025 Filed Mar 3, 2025 22:57 UTC SaleCommon Stock 45 $306.70 $13,801.50
Disclosure

SEC source: 0001624794-25-000020 · wk-form4_1741042654.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,382

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 4, 2024.

Read SEC document
February 18, 2025 Filed Feb 18, 2025 22:36 UTC
Alverson LukeSVP, GC & Secretary
SaleCommon Stock 1,100 $317.81 $349,591.00
Disclosure

SEC source: 0001624794-25-000017 · wk-form4_1739918158.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,534

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 11, 2024.

Read SEC document
February 18, 2025 Filed Feb 18, 2025 22:36 UTC
Sullivan DonEVP, Chief Strategy Officer
SaleCommon Stock 300 $323.55 $97,065.00
Disclosure

SEC source: 0001624794-25-000018 · wk-form4_1739918209.xml · nonDerivative · entry 4

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,075

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 13, 2024.

Read SEC document
February 18, 2025 Filed Feb 18, 2025 22:36 UTC
Sullivan DonEVP, Chief Strategy Officer
SaleCommon Stock 622 $320.77 $199,518.94
Disclosure

SEC source: 0001624794-25-000018 · wk-form4_1739918209.xml · nonDerivative · entry 3

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,375

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 13, 2024.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.53 to $320.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 18, 2025 Filed Feb 18, 2025 22:36 UTC
Sullivan DonEVP, Chief Strategy Officer
SaleCommon Stock 607 $319.97 $194,221.79
Disclosure

SEC source: 0001624794-25-000018 · wk-form4_1739918209.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,997

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 13, 2024.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.47 to $320.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 18, 2025 Filed Feb 18, 2025 22:36 UTC
Sullivan DonEVP, Chief Strategy Officer
SaleCommon Stock 400 $317.98 $127,192.00
Disclosure

SEC source: 0001624794-25-000018 · wk-form4_1739918209.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,604

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 13, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.81 to $318.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:37 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 20 $321.44 $6,428.80
Disclosure

SEC source: 0001624794-25-000019 · wk-form4_1739918255.xml · nonDerivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,848

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:37 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 80 $320.53 $25,642.40
Disclosure

SEC source: 0001624794-25-000019 · wk-form4_1739918255.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,868

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.38 to $320.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:37 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 117 $319.33 $37,361.61
Disclosure

SEC source: 0001624794-25-000019 · wk-form4_1739918255.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,948

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.94 to $319.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:37 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 466 $318.25 $148,304.50
Disclosure

SEC source: 0001624794-25-000019 · wk-form4_1739918255.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,065

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.87 to $318.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:37 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 301 $317.48 $95,561.48
Disclosure

SEC source: 0001624794-25-000019 · wk-form4_1739918255.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,531

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.83 to $317.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:37 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 16 $315.17 $5,042.72
Disclosure

SEC source: 0001624794-25-000019 · wk-form4_1739918255.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,832

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:34 UTC SaleCommon Stock 145 $315.04 $45,680.80
Disclosure

SEC source: 0001624794-25-000016 · wk-form4_1739918066.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,427

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 4, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.